Live feed09:30:00·2hPRReleasevia Quantisnow+1A Breakthrough-Designated Depression Drug Is 86% Through Its Phase 3, With Topline Data Due This YearByQuantisnow·Wall Street's wire, on your screen.CMPS· COMPASS Pathways PlcDFTX· Definium Therapeutics Inc.GHRS· GH Research PLCHELP· Cybin Inc.Health Care
